Dietary cholesterol and its effect on tau protein: A study in apolipoprotein e-deficient and P301L human tau mice

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 4, 2011, Pages 292-301

  Glöckner, Frauke ^a   Meske, Volker ^a   Lütjohann, Dieter ^b   Ohm, Thomas G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Alzheimer disease; ApoE deficiency; Cholesterol; Oxysterols; Tau

Indexed keywords

26 HYDROXYCHOLESTEROL; APOLIPOPROTEIN E; CHOLESTEROL; MUTANT PROTEIN; OXYSTEROL; STEROL; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN NERVE CELL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL METABOLISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GENOTYPE; HISTOPATHOLOGY; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANIMALS; APOLIPOPROTEINS E; BRAIN CHEMISTRY; CELL COUNT; CHOLESTEROL; CHOLESTEROL, DIETARY; DIET; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPIDS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PHOSPHORYLATION; PROTEIN CONFORMATION; TAU PROTEINS;

EID: 79953229512     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318212f185     Document Type: Article

References (72)

1. Schönheit B, Zarski R, Ohm TG. Spatial and temporal relationships between plaques and tangles in Alzheimer pathology. Neurobiol Aging 2004;25:697-711 (Pubitemid 38698241)
2. Lue LF, Kuo YM, Roher AE, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 1999;155:853-62 (Pubitemid 29426831)
3. Ohm TG, Scharnagl H, März W, et al. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's diseaseY related lesions. Acta Neuropathol Berl 1999;98:273-80 (Pubitemid 29396859)
4. Josephs KA, Tsuboi Y, Cookson N, et al. Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, syn-ucleinopathies, and frontotemporal degeneration. Arch Neurol 2004;61: 1579-84 (Pubitemid 39350269)
5. Bernardi L, Maletta RG, Tomaino C, et al. The effects of APOE and tau gene variability on risk of frontotemporal dementia. Neurobiol Aging 2006;27:702-9
6. Weisgraber KH, Roses AD, Strittmatter WJ. The role of apolipoprotein E in the nervous system. Curr Opin Lipidol 1994;5:110-16 (Pubitemid 24116875)
7. Poirier J, Minnich A, Davignon J. Apolipoprotein E, synaptic plasticity and Alzheimer's disease. Ann Med 1995;27:663-70 (Pubitemid 26003731)
8. Mauch DH, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001;294:1354-57 (Pubitemid 33063104)
9. Glöckner F, Meske V, Ohm TG. Genotype-related differences of hippo-campal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease. Neuroscience 2002;114:1103-14
10. Waters RJ, Nicoll JA. Genetic influences on outcome following acute neurological insults. Curr Opin Crit Care 2005;11:105-10 (Pubitemid 40488607)
11. Kivipelto M, Solomon A. Cholesterol as a risk factor for Alzheimer's disease: Epidemiological evidence. Acta Neurol Scand Suppl 2006;185: 50-57 (Pubitemid 44015225)
12. Solomon A, Kareholt I, Ngandu T, et al. Serum cholesterol changes after midlife and late-life cognition: Twenty-one-year follow-up study. Neurology 2007;68:751-56 (Pubitemid 46667900)
13. Evans RM, Hui S, Perkins A, et al. Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology 2004;62: 1869-71 (Pubitemid 38661755)
14. Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia. Lancet 2000;356:1627-31
15. Rockwood K, Kirkland S, Hogan DB, et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002;59:223-27 (Pubitemid 34240938)
16. Sparks DL, Sabbagh M, Connor D, et al. Statin therapy in Alzheimer's disease. Acta Neurol Scand Suppl 2006;185:78-86 (Pubitemid 44015229)
17. Wolozin B, Wang SW, Li NC, et al. Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med 2007;5:20
18. Kandiah N, Feldman HH. Therapeutic potential of statins in Alzheimer's disease. J Neurol Sci 2009;283:230-34
19. Riekse RG, Li G, Petrie EC, et al. Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. J Alzheimers Dis 2006;10:399-406
20. Carlsson CM, Gleason CE, Hess TM, et al. Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease. J Alzheimers Dis 2008;13:187-97 (Pubitemid 352038526)
21. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol Berl 1994;87:554-67 (Pubitemid 24158408)
22. Spillantini MG, Tolnay M, Love S, et al. Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia. Acta Neuropathol (Berl) 1999;97:585-94 (Pubitemid 29231676)
23. Treiber-Held S, Distl R, Albert F, et al. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein: Implications for Alzheimer's disease. J Pathol 2003;200:95-103 (Pubitemid 36592642)
24. Zhang M, Wang X, Jiang F, et al. Mitotic epitopes are incorporated into age-dependent neurofibrillary tangles in Niemann-Pick disease type C. Brain Pathol 2010;20:367-77
25. Distl R, Treiber-Held S, Albert F, et al. Cholesterol storage and tau-pathology in Niemann-Pick type C disease brain. J Pathol 2003;200:104-11 (Pubitemid 36592643)
26. Distl R, Meske V, Ohm TG. Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol 2001; 101:547-54 (Pubitemid 32684752)
27. Gellermann GP, Appel TR, Davies P, et al. Paired helical filaments contain small amounts of cholesterol, phosphatidylcholine and sphingo-lipids. Biol Chem 2006;387:1267-74 (Pubitemid 44402074)
28. Rahman A, Akterin S, Flores-Morales A, et al. High cholesterol diet induces tau hyperphosphorylation in apolipoprotein EYdeficient mice. FEBS Lett 2005;579:6411-16 (Pubitemid 41612160)
29. Boimel M, Grigoriadis N, Lourbopoulos A, et al. Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. J Neuro-pathol Exp Neurol 2009;68:314-25
30. Genis I, Gordon I, Sehayek E, et al. Phosphorylation of tau in apolipo-protein EYdeficient mice. Neurosci Lett 1995;199:5-8
31. Genis L, Chen Y, Shohami E, et al. Tau hyperphosphorylation in apoli-poprotein EYdeficient and control mice after closed head injury. J Neu-rosci Res 2000;60:559-64 (Pubitemid 30252919)
32. Mercken L, Brion JP. Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E. NeuroReport 1995;6:2381-84 (Pubitemid 26010074)
33. Chan A, Shea TB. Dietary and genetically-induced oxidative stress alters tau phosphorylation: Influence of folate and apolipoprotein E deficiency. J Alzheimers Dis 2006;9:399-405 (Pubitemid 44253354)
34. Shen L, Tso P, Woods SC, et al. Brain apolipoprotein E: An important regulator of food intake in rats. Diabetes 2008;57:2092-98
35. Götz J, Chen F, Barmettler R, et al. Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 2001;276:529-34 (Pubitemid 32050347)
36. Lütjohann D, Brzezinka A, Barth E, et al. Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J Lipid Res 2002;43:1078-85 (Pubitemid 34760879)
37. Mercken M, Vandermeeren M, Lubke U, et al. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 1992;84:265-72
38. Jicha GA, Bowser R, Kazam IG, et al. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conforma-tional epitopes on recombinant tau. J Neurosci Res 1997;48:128-32 (Pubitemid 27181338)
39. Ohm TG, Busch C, Bohl J. Unbiased estimation of neuronal numbers in the human nucleus coeruleus during aging. Neurobiol Aging 1997;18: 393-99 (Pubitemid 27435081)
40. Rossler M, Zarski R, Bohl J, et al. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuro-pathol (Berl) 2002;103:363-69 (Pubitemid 36097031)
41. Paxinos G, Franklin KJ. The Mouse Brain in Stereotaxic Coordinates. 2nd ed. San Diego, CA: Academic Press, 1997
42. Ackermann H. BiAS: A Program Package for Biometrical Analysis of Samples. Version 8.4, Hochheim Darmstadt, Germany: Epsilon-Verlag; 2008;1-201
43. Sparks DL, Scheff SW, Hunsaker JC, et al. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 1994;126:88-94
44. Ghribi O, Larsen B, Schrag M, et al. High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol 2006;200:460-67 (Pubitemid 44107924)
45. Howland DS, Trusko SP, Savage MJ, et al. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem 1998;273:16576-82 (Pubitemid 28311445)
46. j/j mice. Arterioscler Thromb Vasc Biol 2007;27:841-49 (Pubitemid 46606715)
47. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein EYdeficient mice created by homologous recombination in ES cells. Cell 1992;71:343-53
48. Zhang SH, Reddick RL, Piedrahita JA, et al. Spontaneous hyper-cholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468-71
49. Paigen B, Holmes PA, Mitchell D, et al. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. Atherosclerosis 1987;64:215-21 (Pubitemid 17047164)
50. Van Ree JH, Gijbels MJ, Van den Broek WJ, et al. Atypical xanthomatosis in apolipoprotein EYdeficient mice after cholesterol feeding. Atherosclerosis 1995;112:237-43
51. Walker LC, Parker CA, Lipinski WJ, et al. Cerebral lipid deposition in aged apolipoprotein-EYdeficient mice. Am J Pathol 1997;151:1371-77 (Pubitemid 27479767)
52. Zhang SH, Reddick RL, Burkey B, et al. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 1994;94:937-45 (Pubitemid 24286433)
53. Gordon I, Genis I, Grauer E, et al. Biochemical and cognitive studies of apolipoprotein-EYdeficient mice. Mol Chem Neuropathol 1996;28: 97-103 (Pubitemid 26275056)
54. Ohkubo N, Lee YD, Morishima A, et al. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/ glycogen synthase kinase-3beta cascade. FASEB J 2003;17:295-97
55. Lopez-Miranda J, Ordovas JM, Ostos MA, et al. Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler Thromb Vasc Biol 1997;17:1765-73 (Pubitemid 27423999)
56. Jansen PJ, Lutjohann D, Thelen KM, et al. Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels. J Alzheimers Dis 2009;18:319-29
57. Barnard DE, Lewis SM, Teter BB, et al. Open- and closed-formula laboratory animal diets and their importance to research. J Am Assoc Lab Anim Sci 2009;48:709-13
58. Wang X, Luebbe P, Gruenstein E, et al. Apolipoprotein E (ApoE) peptide regulates tau phosphorylation via two different signaling pathways. J Neurosci Res 1998;51:658-65 (Pubitemid 28115067)
59. Cedazo-Minguez A, Popescu BO, Blanco-Millan JM, et al. Apolipopro-tein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta. J Neurochem 2003;87:1152-64 (Pubitemid 37492856)
60. Xu PT, Li YJ, Qin XJ, et al. Differences in apolipoprotein E3/3 and E4/4 alleleYspecific gene expression in hippocampus in Alzheimer disease. Neurobiol Dis 2006;21:256-75
61. Xu PT, Li YJ, Qin XJ, et al. A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci 2007;36:313-31
62. Xu PT, Schmechel D, Rothrock CT, et al. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: Human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol Dis 1996;3:229-45 (Pubitemid 26391326)
63. Xu PT, Gilbert JR, Qiu HL, et al. Regionally specific neuronal expression of human APOE gene in transgenic mice. Neurosci Lett 1998;246: 65-68 (Pubitemid 28207077)
64. Crawford F, Wood M, Ferguson S, et al. Apolipoprotein E genotypeY dependent hippocampal and cortical responses to traumatic brain injury. Neuroscience 2009;159:1349-62
65. Rapp A, Gmeiner B, Huttinger M. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astro-cytes. Biochimie 2006;88:473-83 (Pubitemid 43867898)
66. Michikawa M, Fan QW, Isobe I, et al. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem 2000;74:1008-16 (Pubitemid 30104296)
67. Wood WG, Schroeder F, Avdulov NA, et al. Recent advances in brain cholesterol dynamics: Transport, domains, and Alzheimer's disease. Lipids 1999;34:225-34 (Pubitemid 29169625)
68. Heverin M, Meaney S, Lutjohann D, et al. Crossing the barrier: Net flux of 27-hydroxycholesterol into the human brain. J Lipid Res 2005;46: 1047-52
69. Gill S, Chow R, Brown AJ. Sterol regulators of cholesterol homeostasis and beyond: The oxysterol hypothesis revisited and revised. Prog Lipid Res 2008;47:391-404
70. Espenshade PJ, Hughes AL. Regulation of sterol synthesis in eukaryotes. Annu Rev Genet 2007;41:401-27
71. Björkhem I, Cedazo-Minguez A, Leoni V, et al. Oxysterols and neuro-degenerative diseases. Mol Aspects Med 2009;30:171-79
72. Marwarha G, Dasari B, Prasanthi JR, et al. Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. J Alzheimers Dis 2010;19:1007-19